The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Utility of FDG-PET scanning in lymphoma by WHO classification
Abstract
We retrospectively evaluated 18fluoro-2-deoxyglucose positron emission tomography (FDG-PET) scans in 172 patients with lymphoma and correlated results with pathologic diagnosis using the World Health Organization (WHO) classification system. In total, FDG-PET detected disease in at least one site in 161 patients (94%) and failed to detect disease in 11 patients (6%). The most frequent lymphoma diagnoses were diffuse large B-cell lymphoma (LBCL; n = 51), Hodgkin lymphoma (HL; n = 47), follicular lymphoma (FL; n = 42), marginal zone lymphoma (MZL; n = 12), mantle cell lymphoma (MCL; n = 7), and peripheral T-cell lymphoma (PTCL; n = 5). FDG-PET detected disease in 100% of patients with LBCL and MCL and in 98% of patients with HL and FL. In contrast, FDG-PET detected disease in only 67% of MZL and 40% of PTCL. Comparison with bone marrow biopsies showed that FDG-PET was not reliable for detection of bone marrow involvement in any lymphoma subtype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
Moog, F., Bangerter, M., Diederichs, C. G., Guhlmann, A., Kotzerke, J., Merkle, E., Kolokythas, O., Herrmann, F., & Reske, S. N. (1997) · Radiology · doi:10.1148/radiology.203.3.9169707 · Cited by 309
Jerusalem, G., Beguin, Y., Najjar, F., Hustinx, R., Fassotte, M. F., Rigo, P., & Fillet, G. (2001) · Annals of Oncology · doi:10.1023/a:1011169332265 · Cited by 268
Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
Newman, J. S., Francis, I. R., Kaminski, M. S., & Wahl, R. L. (1994) · Radiology · doi:10.1148/radiology.190.1.8259386 · Cited by 265
Stumpe, K. D. M., Urbinelli, M., Steinert, H. C., Glanzmann, C., Buck, A., & von Schulthess, G. K. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050275 · Cited by 261
Naumann, R., Vaic, A., Beuthien‐Baumann, B., Bredow, J., Kropp, J., Kittner, T., Franke, W., & Ehninger, G. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03147.x · Cited by 212
Whole-body FDG-PET imaging in the management of patients with cancer
Hustinx, R., Bénard, F., & Alavi, A. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.29272 · Cited by 199
Self-citationLapela, M., Leskinen, S., Minn, H., Lindholm, P., Klemi, P., Soderstrom, K., Bergman, J., Haaparanta, M., Ruotsalainen, U., & Solin, O. (1995) · Blood · doi:10.1182/blood.v86.9.3522.bloodjournal8693522 · Cited by 174
Spaepen, K., Stroobants, S., Dupont, P., Thomas, J., Vandenberghe, P., Balzarini, J., De Wolf‐Peeters, C., Mortelmans, L., & Verhoef, G. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03169.x · Cited by 169
Hoffmann, M., Kletter, K., Diemling, M., Becherer, A., Pfeffel, F., Petkov, V., Chott, A., & Raderer, M. (1999) · Annals of Oncology · doi:10.1023/a:1008312726163 · Cited by 165
Cited by
Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., & Lister, T. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8800 · Cited by 5,715
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Self-citationShankland, K. R., Armitage, J. O., & Hancock, B. W. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60605-9 · Cited by 641
18F-FDG PET/CT Imaging In Oncology
Almuhaideb, A., Papathanasiou, N., & Bomanji, J. (2011) · Annals of Saudi Medicine · doi:10.4103/0256-4947.75771 · Cited by 388
Metadata
- Authors
- Elstrom, R., Guan, L., Baker, G., Nakhoda, K., Vergilio, J.-A., Zhuang, H., Pitsilos, S., Bagg, A., Downs, L., Mehrotra, A., Kim, S., Alavi, A., & Schuster, S. J.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2003-05-15
- Volume
- 101
- Issue
- 10
- Pages
- 3875-3876
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2120617891
- Cited by
- 437
- References
- 10
- FWCI
- 14.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Utility of FDG-PET scanning in lymphoma by WHO classification. https://app.cochat.ai/papers/10.1182/blood-2002-09-2778
- The paper
- Elstrom, R., Guan, L., Baker, G., Nakhoda, K., Vergilio, J.-A., Zhuang, H., Pitsilos, S., Bagg, A., Downs, L., Mehrotra, A., Kim, S., Alavi, A., & Schuster, S. J. (2003). Utility of FDG-PET scanning in lymphoma by WHO classification. Blood. https://doi.org/10.1182/blood-2002-09-2778
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.